Trial Profile
An Open-label, Single-dose Study to Assess the Pharmacokinetics of Imrecoxib in Subjects With Impaired Hepatic Function
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Imrecoxib (Primary)
- Indications Inflammation; Osteoarthritis
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 03 Jun 2015 New trial record